【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Aranesp
04.1.2 Epogen/Procrit
04.1.3 Mircera
04.1.4 Renvela
04.1.5 Avapro
04.1.6 Bystolic
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Etiology
07.2 Epidemiology
07.2.1 Mortality
07.2.2 Prevalence of CKD
08.Pipeline Analysis
08.1 Emerging Treatment Options
09.Market Landscape
09.1 Market Overview
09.2 Market Size and Forecast
09.3 Five Forces Analysis
10.Segmentation of Global CKD Market by Route of Administration
10.1 Oral
10.2 SC
10.3 IV
11.Segmentation of Global CKD Market by Mechanism of Action
11.1 ARBs
11.2 ACEIs
11.3 ESAs
11.4 PH Binders
11.5 Vasodilators
12.Geographical Segmentation
12.1 CKD Drugs Market in Americas
12.1.1 Market Size and Forecast
12.2 CKD Drugs Market in EMEA Region
12.2.1 Market Size and Forecast
12.3 CKD Drugs Market in APAC Region
12.3.1 Market Size and Forecast
13.Buying Criteria
14.Market Growth Drivers
15.Drivers and their Impact
16.Market Challenges
17.Impact of Drivers and Challenges
18.Market Trends
19.Trends and their Impact
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 Competitive Assessment of Top Drugs Used for CKD Treatment
20.2.2 Amgen
20.2.3 Actavis
20.2.4 Johnson & Johnson
20.2.5 F. Hoffmann-La Roche
20.2.6 Sanofi
20.3 Other Prominent Vendors
21.Key Vendor Analysis
21.1 Amgen
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue 2013
21.1.4 Product Portfolio by Revenue 2013
21.1.5 Business Segmentation by Revenue 2012 and 2013
21.1.6 Geographical Segmentation by Revenue 2013
21.1.7 Business Strategy
21.1.8 Recent Developments
21.1.9 SWOT Analysis
21.2 Actavis
21.2.1 Key Facts
21.2.2 Business Description
21.2.3 Business Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Sales by Geography
21.2.6 Business Strategy
21.2.7 Key Information
21.2.8 SWOT Analysis
21.3 Johnson & Johnson
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2013
21.3.4 Business Segmentation by Revenue 2012 and 2013
21.3.5 Geographical Segmentation by Revenue 2013
21.3.6 Business Strategy
21.3.7 Recent Developments
21.3.8 SWOT Analysis
21.4 F. Hoffmann-La Roche Ltd.
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation
21.4.4 Business Segmentation by Revenue 2012 and 2013
21.4.5 Sales by Geography
21.4.6 Business Strategy
21.4.7 Key Information
21.4.8 SWOT Analysis
21.5 Sanofi SA
21.5.1 Key Facts
21.5.2 Business Description
21.5.3 Business Segmentation
21.5.4 Revenue by Business Segmentation
21.5.5 Revenue Comparison 2012 and 2013
21.5.6 Sales by Geography
21.5.7 Business Strategy
21.5.8 Key Developments
21.5.9. SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Segmentation of Global CKD Drugs Market
Exhibit 2: Market Research Methodology
Exhibit 3: Stages of CKD
Exhibit 4: Causes of CKD
Exhibit 5: Prevalence of CKD among NHANES (US) Participants by CKD Stage 1988-2012
Exhibit 6: Global CKD Drugs Market 2014-2019 (US$ billion)
Exhibit 7: Drivers and Challenges in Global CKD Drugs Market
Exhibit 8: Segmentation of Global CKD Drugs Market by Route of Administration
Exhibit 9: Segmentation of Global CKD Drugs Market by Mechanism of Action
Exhibit 10: Segmentation of Global CKD Drugs Market by Geography 2014
Exhibit 11: Segmentation of Global CKD Drugs Market by Geography 2019
Exhibit 12: Segmentation of Global CKD Drugs Market by Geography 2014-2019
Exhibit 13: CKD Drugs Market in Americas 2014-2019 (US$ billion)
Exhibit 14: CKD Drugs Market in EMEA Region 2014-2019 (US$ billion)
Exhibit 15: CKD Drugs Market in APAC Region 2014-2019 (US$ billion)
Exhibit 16: Comparison of Percentage of Population Age 65 and Older 2012 and 2050
Exhibit 17: Revenue Comparison of Top Drugs Used for Treatment of CKD 2013 (US$ million)
Exhibit 18: Epogen: Revenue Comparison and YoY Growth Rate 2011-2013 (US$ million)
Exhibit 19: Aranesp: Revenue Comparison and YoY Growth 2011-2013 (US$ million)
Exhibit 20: Bystolic: Revenue Comparison and YoY Growth Rate 2011-2013 (US$ million)
Exhibit 21: Procrit: Revenue Comparison and YoY Growth Rate 2011-2013 (US$ million)
Exhibit 22: Mircera: Revenue Comparison and YoY Growth Rate 2011-2013 (US$ million)
Exhibit 23: Renvela: Revenue Comparison and YoY Growth Rate 2011-2013 (US$ million)
Exhibit 24: Avapro: Revenue Comparison and YoY Growth Rate 2011-2013 (US$ million)
Exhibit 25: Amgen: Business Segmentation by Revenue 2013
Exhibit 26: Amgen: Product Portfolio by Revenue 2013
Exhibit 27: Amgen: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 28: Amgen: Geographical Segmentation by Revenue 2013
Exhibit 29: Global CKD Drugs Market Market Business Segmentation 2013
Exhibit 30: Global CKD Drugs Market Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 31: Actavis : Sales by Geography (in US$ million)
Exhibit 32: Johnson & Johnson: Business Segmentation by Revenue 2013
Exhibit 33: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 34: Johnson & Johnson: Geographical Segmentation by Revenue 2013
Exhibit 35: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 36: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 37: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 38: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 39: Sanofi SA: Business Segmentation
Exhibit 40: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 41: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 42: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル：慢性腎臓病（CKD）治療薬の世界市場2015-2019■ 英文：Global Chronic Kidney Disease (CKD) Drugs Market 2015-2019
■ 発行日：2015年3月11日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5417
■ 調査対象地域：グローバル
- シングルユース（単回使用）バイオプロセスの世界市場：製品別（培地関連バッグ・容器、ろ過アセンブリ、使い捨て・単回使用バイオリアクター、使い捨てミキサー）、用途別（ろ過、貯蔵、細胞構造、混合、精製）、エンドユーザー別、地域別予測Global Single-use Bioprocessing Market to reach USD 11.4 billion by 2025. Global Single-use Bioprocessing Market valued approximately USD 2.6 billion in 2016 is anticipated to grow with a healthy growth rate of more than 17.90% over the forecast period 2017-2025. Major factors fueling market growth are the increasing demand for biopharmaceuticals, high energy efficiency, low water usage, less floo …
- スチレン系ブロック共重合体（SBC）及び誘導体の世界市場2016-2020：SBS、SIS、SEBS、HSBCStyrenic block copolymers, commonly known as SBCs, belong to the family of thermoplastic elastomers. These polymers are consumed in bulk compared with other thermoplastic elastomers and exhibit properties similar to rubber, though they are processed as thermoplastics. They are added in additives and other high-performance polymeric compounds for the formulation of many products. Technavio’s analys …
- 世界の精密農業技術市場The global population is expected to rise up to, nearly, 7.5 billion by the year 2020, and the ability to manage and tackle the ever increasing demand for food would, in all likelihood, continue to plague the world. Global warming continues to be an influential deciding factor in determining agriculture productivity, as well as the soil properties, and sustainability of natural resources. The effe …
- アジアの産業自動化制御市場：PLC、DCS、SCADA、MES、APCTechnavio research analyst predicts the industrial automation control market in APAC to grow steadily at a CAGR of 8% during the forecast period. The surge in the demand for chemical and petrochemical products from APAC is the primary growth driver for this market. The high adoption of automation control solutions across chemicals plants in China, Japan, South Korea, India, and Taiwan has been con …
- 世界のセレン市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of selenium, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing selenium production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: selenium prod …
- 癌免疫療法の世界市場：製品別（腫瘍溶解性ウイルス療法・癌ワクチン、モノクローナル抗体、免疫調節剤）、癌種類別（乳房、肺）、セグメント予測The global cancer immunotherapy market size is likely to reach USD 126.9 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.6% during the forecast period. Increasing patient pool and higher mortality rate are augmenting the need for cancer immunotherapy globally. Furthermore, increasing number of approvals for new immunotherapeutic drugs is driving the …
- グローバル石炭市場分析Coal is the most used fossil fuel in today's world. Even though there are many renewable options also available today, coal remains the most widely used fuel used for electricity generation in both developed and emerging economies. The coal industry is a highly competitive market and there are several players that have been operating in the industry for many years now. Worldwide, the coal industry …
- 民間航空機用バッテリー及び付属品の世界市場The global commercial aircraft batteries and accessories market is estimated to grow at a CAGR of 7.3% from 2014 to 2019. Although the developing markets (such as the China, India, and Japan) hold larger shares in the global commercial aircraft batteries and accessories market, the Middle East region is expected to grow at the highest CAGR of 8.4% in the forecast period. The growth of the commerci …
- 世界のベーカリー及びシリアル市場動向（2014年4月）：ニュース・イベントSynopsis Using this report, marketers will effectively gain an insight into the latest happenings in the global bakery & cereals market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global bakery & cereals market on a monthly basis. Scope The report provides a review of the latest news and key events in …
- Left Ventricular Hypertrophy：グローバル臨床試験レビューH2, 2013Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2013" provides data on the Left Ventricular Hypertrophy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Left Ventricular Hypertrophy. It includes an overview …
- シネオールの世界市場2015Cineole (CAS 470-82-6) Market Research Report 2015 aims at providing comprehensive data on Cineole market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Cineole description, covers its application areas, manufacturing methods, patterns. It captures Cineole market trends, pays close attention to Cineole manufacturers and names suppliers. Besides, the r …
- Consort Medical plc：市場シェア分析Consort Medical plc Market Share Analysis Summary GlobalData’s new report, “Consort Medical plc Market Share Analysis” provides in-depth information on Consort Medical plc’s market position in the different medical equipment markets it operates in. The report provides Consort Medical plc market share information in two key market categories – Metered Dose Inhaler Devices and Needle Free Injections …
- BRIC地域における心臓血管補綴処置動向（～2020）BRIC Cardiovascular Prosthetic Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Cardiovascular Prosthetic Procedures Outlook to 2020", provides key procedures data on the BRIC Cardiovascular Prosthetic Procedures. The report provides procedure volumes within market category - Septal Occluder Procedures (Atrial Septal Defect (ASD) Occluder, Ventricular Septal Defect (VSD) Occluder …
- 世界のパワートレインセンサー市場：ICE車両用センサー種類別（位置、圧力、速度、温度）、EV用センサー種類別（位置、温度、電流、電圧）、推進別、パワートレインサブシステム別、車両タイプ別、EVタイプ別、地域別“Increasing adoption of vehicles equipped with modern ICE drivetrain and HEVs are anticipated to trigger the growth of the powertrain sensor market.” The global powertrain sensor market is projected to grow at a CAGR of 2.8% to reach USD 24.7 billion by 2027, from an estimated USD 19.8 billion in 2019. Increasing adoption of powertrain sensors required for better fuel economy and decrease in carbo …
- WaaS（Workspace as a Service）ソリューションの世界市場：VDI（仮想デスクトップインフラ）、クラウド型デスクトップサービス等Workspace services have developed its significance around the globe as WaaS solutions and services offers crucial benefits to organizations like flexible workspace which enhances user satisfaction, and centralized storage which reduces the chance of data loss and there by provides security. It also provides mobility and flexibility to fast changing business needs. The companies providing WaaS solu …
